A2 Biotherapeutics raises $80m to advance CAR-T therapies for …

A2 Biotherapeutics Raises $80m To Advance CAR-T Therapies For …

3 weeks from now

Jan 10, 2025  · US-based biotech company A2 Biotherapeutics (A2 Bio) has secured $80m in funding to advance its pipeline of chimeric antigen receptor (CAR)-T cell therapies for solid …

pharmaceutical-technology.com

A2 Biotherapeutics Secures $80 Million For Innovative Cancer …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, Inc. (A2 Bio), a pioneering company in the field of cell therapies, recently announced the successful completion of an $80 million Series C financing round. This …

investorshangout.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing company based in Agoura Hills, Calif. A2 Bio plans to direct the Series C …

businesswire.com

A2 Biotherapeutics Closes $80 Million Series C Financing To …

3 weeks from now

Jan 9, 2025  · AGOURA HILLS, Calif., January 09, 2025--A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to …

yahoo.com

A2 Bio Closes $80 Million Series C Financing Round

3 weeks from now

Jan 9, 2025  · Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a …

pacbiztimes.com

Cell Therapy Startup A2 Biotherapeutics Nets $80M Series C

3 weeks from now

Jan 9, 2025  · Jim Robinson, A2 Biotherapeutics CEO (David Paul Morris/Getty Images) January 9, 2025 11:41 AM EST. Financing. Cell ther­a­py start­up A2 Bio­ther­a­peu­tics nets $80M Se­ries C.

endpts.com

A2 Biotherapeutics: $80 Million (Series C) Raised For Advancing ...

3 weeks from now

A2 Biotherapeutics – a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to target tumor cells and protect normal cells selectively – announced the closing …

pulse2.com

A2 Biotherapeutics Completes $80M Series C - Vcnewsdaily.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics (A2 Bio) is a clinical-stage biotech company developing first-in-class logic-gated cell therapies to address the high unmet need in cancers. A2 Bio invented …

vcnewsdaily.com

A2 Biotherapeutics Raises $80M Series C Funding - Finsmes.com

3 weeks from now

Jan 9, 2025  · A2 Biotherapeutics, an Agoura Hills, CA-based clinical-stage cell therapy company developing logic-gated cell therapies to selectively target tumor cells and protect normal cells, …

finsmes.com

A2 Biotherapeutics Closes $71.5M Series B To Begin Clinical …

3 weeks from now

Oct 6, 2020  · A2 Biotherapeutics, established in 2018, is a fully integrated discovery, development and manufacturing organization with more than 40 staff located in Agoura Hills, California. The …

prnewswire.com

A2 Biotherapeutics Receives $57M Series A Funding

3 weeks from now

A2 Biotherapeutics, a biotechnology company developing innovative cell therapies for cancer patients, today announced its official launch. The company, founded in 2018 by veteran …

vcnewsdaily.com

A2 Biotherapeutics Emerges From Stealth Mode With $57M Series …

3 weeks from now

Nov 5, 2019  · A2 Biotherapeutics' mission is to beat cancer via tumor-specific targeting by addressing targets gained or lost in cancer cells which unequivocally discriminate tumor from …

prnewswire.com

Geneos Therapeutics Secures $17 Million In Series A2 Financing To ...

3 weeks from now

Mar 24, 2022  · The rate of death from liver cancer in the U.S. has increased 43% from 2000 to 2016 and with a 5-year survival rate of 18% for advanced liver cancer, it is the second most …

prnewswire.com